Definition: Disorders that fulfil some of the features of anorexia nervosa but in which the overall clinical picture does not justify that diagnosis. For instance, one of the key symptoms, such as amenorrhoea or marked dread of being fat, may be absent in the presence of marked weight loss and weight-reducing behaviour. This diagnosis should not be made in the presence of known physical disorders associated with weight loss.

air operator segmented weight

weight and size [ maximum weight | per axle weight | total authorised weight | total laden weight | towing weight ]

gravity structure [ gravity-base structure | gravity base structure | gravity platform ]

Definition: A syndrome characterized by repeated bouts of overeating and an excessive preoccupation with the control of body weight, leading to a pattern of overeating followed by vomiting or use of purgatives. This disorder shares many psychological features with anorexia nervosa, including an overconcern with body shape and weight. Repeated vomiting is likely to give rise to disturbances of body electrolytes and physical complications. There is often, but not always, a history of an earlier episode of anorexia nervosa, the interval ranging from a few months to several years. | Bulimia NOS Hyperorexia nervosa

Definition: A disorder characterized by deliberate weight loss, induced and sustained by the patient. It occurs most commonly in adolescent girls and young women, but adolescent boys and young men may also be affected, as may children approaching puberty and older women up to the menopause. The disorder is associated with a specific psychopathology whereby a dread of fatness and flabbiness of body contour persists as an intrusive overvalued idea, and the patients impose a low weight threshold on themselves. There is usually undernutrition of varying severity with secondary endocrine and metabolic changes and disturbances of bodily function. The symptoms include restricted dietary choice, excessive exercise, induced vomiting and ...[+++]purgation, and use of appetite suppressants and diuretics.

G. whereas all RPAS rules in place in Europe are tailored to assessing the safety risk of the operation; whereas such RPAS rules are ‘operator centric’ and do not take the ‘aircraft centric’ approach used in manned aviation; whereas the risk depends not only on the type of machine and its characteristics (weight, speed, etc.), but also on additional factors, such as the area overflown, the altitude, the expertise of the operator and the particular type of operation and the ability of the operator to deal with unforeseen circumstances;

G. whereas all RPAS rules in place in Europe are tailored to assessing the safety risk of the operation; whereas such RPAS rules are ‘operator centric’ and do not take the ‘aircraft centric’ approach used in manned aviation; whereas the risk depends not only on the type of machine and its characteristics (weight, speed, etc.), but also on additional factors, such as the area overflown, the altitude, the expertise of the operator and the particular type of operation and the ability of the operator to deal with unforeseen circumstances;

G. whereas all RPAS rules in place in Europe are tailored to assessing the safety risk of the operation; whereas such RPAS rules are ‘operator centric’ and do not take the ‘aircraft centric’ approach used in manned aviation; whereas the risk depends not only on the type of machine and its characteristics (weight, speed, etc.), but also on additional factors, such as the area overflown, the altitude, the expertise of the operator and the particular type of operation and the ability of the operator to deal with unforeseen circumstances;

Until 23 September 2016, the limits referred to in the first subparagraph may be regarded as kept, if the polycyclic aromatics (PCA) extract is less than 3 % by weight as measured by the Institute of Petroleum standard IP 346:1998 (Determination of PCA in unused lubricating base oils and asphaltene free petroleum fractions — Dimethyl sulphoxide extraction refractive index method), provided that compliance with the limits of BaP and of the listed PAHs, as well as the correlation of the measured values with the PCA extract, is measured by the manufacturer or importer every six ...[+++]months or after each major operational change, whichever is earlier’.